Oculis Holding AG Logo

Oculis Holding AG

OCS | IC

Overview

Corporate Details

ISIN(s):
CH1242303498 (+1 more)
LEI:
5067005370C2KK324336
Country:
Switzerland
Address:
Bahnhofstrasse 7, 6300 Zug
Website:
N/A
Sector:
Health Care
Industry:
Biotechnology

Description

Oculis Holding AG is a Swiss biopharma company developing innovative eye treatments. Its focus is on addressing major unmet medical needs in ophthalmology.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-09 22:05
Directors' Dealings
Oculis Publishes Notifications of Transactions by Persons Discharging Manageria…
English 940 bytes
2025-06-05 10:00
Declaration of Voting Results & Voting Rights Announcements
Oculis birtir niðurstöður aðalfundar 2025
Icelandic 7.7 KB
2025-06-05 10:00
AGM Report
Oculis Publishes Results of 2025 Annual General Meeting
English 6.4 KB
2025-06-03 23:00
Directors' Dealings
Oculis Publishes Notifications of Transactions by Persons Discharging Manageria…
English 949 bytes
2025-06-03 10:00
Regulatory News Service
Oculis to Participate in Upcoming June Investor Conferences
English 4.3 KB
2025-05-09 22:05
General Meeting Notice
Oculis birtir boð á aðalfund
Icelandic 4.6 KB
2025-05-09 22:05
General Meeting Notice
Oculis Publishes Invitation to the Annual General Meeting
English 4.2 KB
2025-05-09 21:05
Regulatory News Service
Oculis Publishes Invitation to the ..
Icelandic 4.6 KB
2025-05-09 21:05
Regulatory News Service
Oculis Publishes Invitation to the ..
English 4.2 KB
2025-05-08 22:05
Earnings Release
Oculis birtir uppgjör fyrir fyrsta ársfjórðung 2025 og kynnir áfanga í rekstri …
Icelandic 22.3 KB
2025-05-08 22:05
Earnings Release
Oculis Reports Q1 Financial Results and Provides Company Update
English 19.6 KB
2025-05-08 21:05
Earnings Release
Oculis Reports Q1 Financial Results..
Icelandic 22.1 KB
2025-05-08 21:05
Earnings Release
Oculis Reports Q1 Financial Results..
English 19.4 KB
2025-05-07 09:00
Regulatory News Service
Oculis to Present at Upcoming May I..
English 4.9 KB
2025-05-01 09:00
Regulatory News Service
Oculis to Present its Innovative La..
English 19.0 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
OSE Immunotherapeutics Logo OSE Immunotherapeutics France OSE
Ovoca Bio Plc Logo Ovoca Bio Plc Ireland OVXA
Oxford Biomedica PLC Logo Oxford Biomedica PLC United Kingdom OXB
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC United Kingdom OCTHF
Oxurion NV Logo Oxurion NV Belgium OXUR
PCI Biotech Holding Logo PCI Biotech Holding Norway PCIB
Pentixapharm Holding AG Logo Pentixapharm Holding AG Germany PTP
Perpetua Medical AB Logo Perpetua Medical AB Sweden PERP
PharmaLundensis AB Logo PharmaLundensis AB Sweden PHAL
Pharma Mar S.A. Logo Pharma Mar S.A. Spain PHM